Matthew A Brown Selected Research

Spondylarthropathies

1/2020	Altered Repertoire Diversity and Disease-Associated Clonal Expansions Revealed by T Cell Receptor Immunosequencing in Ankylosing Spondylitis Patients.
10/2017	Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.
4/2015	The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew A Brown Research Topics

Disease

41	Ankylosing Spondylitis 12/2023 - 10/2004
15	Inflammation (Inflammations) 01/2023 - 01/2005
10	Rheumatoid Arthritis 11/2017 - 09/2002
9	Axial Spondyloarthritis 12/2023 - 08/2012
9	Arthritis (Polyarthritis) 01/2021 - 01/2005
8	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 11/2010
6	Necrosis 01/2022 - 11/2015
6	Spondylitis 01/2019 - 07/2012
6	Chondrocalcinosis (Pseudogout) 01/2017 - 10/2002
5	Non-Radiographic Axial Spondyloarthritis 01/2023 - 06/2013
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 06/2002
4	Myositis Ossificans (Fibrodysplasia Ossificans Progressiva) 11/2023 - 05/2006
4	Crohn Disease (Crohn's Disease) 01/2021 - 06/2002
4	Osteoporosis 01/2020 - 03/2005
4	Neoplasms (Cancer) 11/2018 - 10/2012
4	Disease Progression 01/2017 - 03/2011
4	Joint Diseases (Joint Disease) 06/2014 - 04/2006
3	Calcinosis 01/2023 - 01/2012
3	Genetic Risk Score 04/2022 - 01/2020
3	Hypertension (High Blood Pressure) 01/2022 - 01/2020
3	Sacroiliitis 01/2022 - 01/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2011
3	Ileitis 01/2021 - 07/2012
3	Back Pain (Backache) 01/2021 - 06/2013
3	Spondylarthropathies 01/2020 - 04/2015
3	Disease Susceptibility (Diathesis) 01/2019 - 02/2010
3	Genetic Predisposition to Disease (Genetic Predisposition) 08/2016 - 09/2002
3	Multiple Sclerosis 10/2010 - 03/2010
2	Mycoses (Diseases, Fungus) 01/2023 - 07/2012
2	Heterotopic Ossification (Ectopic Ossification) 01/2023 - 03/2011
2	Autoimmune Diseases (Autoimmune Disease) 06/2022 - 01/2019
2	Systemic Scleroderma (Systemic Sclerosis) 06/2022 - 01/2021
2	Uveitis 01/2022 - 07/2012
2	Hemorrhage 10/2021 - 01/2021
2	Dysbiosis 01/2021 - 10/2020
2	Adenocarcinoma 01/2021 - 10/2012
2	Hypertrophy 01/2021 - 04/2005
2	Heart Failure 01/2021 - 01/2020
2	Pain (Aches) 01/2018 - 03/2014
2	Asthma (Bronchial Asthma) 06/2014 - 09/2011
2	Osteoarthritis 12/2013 - 02/2012
2	Jeune syndrome 11/2013 - 11/2013
2	Ciliopathies 11/2013 - 11/2013
2	Ankylosis 11/2012 - 01/2012
2	Spondylarthritis (Spinal Arthritis) 07/2012 - 06/2002

Drug/Important Bio-Agent (IBA)

14	HLA-B27 Antigen (HLA B27 Antigen)IBA 12/2023 - 07/2011
14	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2002
8	C-Reactive ProteinIBA 01/2023 - 01/2009
8	HLA-B Antigens (HLA-B)IBA 01/2020 - 09/2011
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 02/2012
7	HLA-DRB1 Chains (HLA DRB1)IBA 01/2019 - 01/2003
6	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2010
6	Interleukin-23 (Interleukin 23)IBA 01/2022 - 04/2009
6	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2019 - 01/2012
5	InterleukinsIBA 01/2023 - 02/2010
5	Peptides (Polypeptides)IBA 12/2022 - 07/2011
5	AntigensIBA 12/2022 - 01/2007
5	CytokinesIBA 01/2017 - 01/2005
5	diphosphoric acid (pyrophosphoric acid)IBA 01/2012 - 04/2005
4	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 04/2022 - 08/2007
4	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 01/2003
4	AminopeptidasesIBA 01/2018 - 07/2011
4	Amino Acids FDA Link 10/2017 - 12/2014
4	Proteoglycans (Proteoglycan)IBA 01/2017 - 11/2012
3	curdlanIBA 01/2021 - 07/2012
3	AutoantibodiesIBA 01/2021 - 01/2009
3	HLA-C Antigens (HLA-C)IBA 01/2019 - 11/2010
3	Calcium PyrophosphateIBA 01/2017 - 10/2002
3	RNA (Ribonucleic Acid)IBA 12/2013 - 03/2011
3	EnzymesIBA 01/2013 - 05/2011
3	Interleukin-1 (Interleukin 1)IBA 01/2013 - 10/2004
2	PalovaroteneIBA 11/2023 - 01/2023
2	InterferonsIBA 10/2023 - 06/2022
2	RacivirIBA 01/2023 - 01/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 09/2021
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2020 - 06/2013
2	HLA-A Antigens (HLA-A)IBA 10/2020 - 01/2019
2	Untranslated RNA (Noncoding RNA)IBA 01/2020 - 06/2016
2	LigandsIBA 01/2020 - 01/2009
2	Uric Acid (Urate)IBA 01/2020 - 01/2011
2	Fibrillin-1IBA 01/2020 - 01/2016
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 07/2012
2	EpitopesIBA 01/2020 - 04/2014
2	micaIBA 01/2020 - 11/2018
2	HLA-DPB1 antigen (HLA DPB1)IBA 01/2019 - 10/2010
2	Aligeron (AS 2)IBA 01/2018 - 04/2005
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018 - 01/2009
2	Serine (L-Serine)FDA Link 10/2017 - 03/2011
2	Interleukin-6 (Interleukin 6)IBA 11/2015 - 01/2013
2	Phosphates (Orthophosphate)IBA 01/2015 - 04/2012
2	P-2 (P 2)IBA 06/2014 - 01/2013
2	Initiator Codon (Start Codon)IBA 03/2014 - 04/2005
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2014 - 01/2005
2	OsteocalcinIBA 03/2014 - 11/2012

Therapy/Procedure

14	Therapeutics 10/2023 - 01/2005
3	Transjugular Intrahepatic Portasystemic Shunt 10/2021 - 02/2020
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2021 - 02/2020
2	Endurance Training 01/2022 - 01/2021